References
- Snell RS. The pigmentary changes occurring in the breast skin during pregnancy following estrogen treatment. J Invest Dermatol. 1964;42:181–186.
- Perez M, Sanchez JL, Aguilo F. Endocrinologic profile of patients with idiopathic melasma. J Invest Dermatol. 1983; 81:543–545.
- Lutti RJ, Fridmanis M, Misrunas AL. Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of melasma. J Clin Endocrinol Metab. 1985;61:28–31.
- Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. J Am Acad Dermatol. 1986;15:894–899.
- Maeda K, Tomita Y. Mechanism of the inhibitory effect of tranexamic acid on melanogenesis in cultured human melanocytes in the presence of keratinocyte-conditioned medium. J Health Sci. 2007;53:389–396.
- Matsunaga K. Treatment of melasma: Efficacy of topical and systemic treatment. Skin Surgery. 1993;2:52–53.
- Maeda K, Naganuma M. Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation. J Photochem Photobiol B. 1998;47:136–141.
- Endo Y, Nishimura S, Miura A. Deep-vein thrombosis induced by tranexamic acid in idiopathic thrombocytopenic purpura [letter]. JAMA. 1988;259:3561–3562.
- Woo KS, Tse LKK, Woo JLF, Vallance-Owen J. Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy. Br J Clin Pract. 1989;43:465–466.
- Taparia M, Cordingley FT, Leahy MF. Pulmonary embolism associated with tranexamic acid in severe acquired haemophilia. Eur J Haematol. 2002;68:307–309.
- Rydin E, Lundberg PO. Tranexamic acid and intracranial thrombosis [letter]. Lancet. 1976;2:49.
- Mekontso-Dessap A, Collet JP, Lebrun-Vignes B, Soubrié C, Thomas D, Montalescot G. Acute myocardial infarction after oral tranexamic acid treatment initiation. Int J Cardiol. 2002;83:267–268.
- Crouch ER Jr, Williams PB, Gray MK, Crouch ER, Chames M. Topical aminocaproic acid in the treatment of traumatic hyphema. Arch Ophthalmol. 1997;115: 1106–1112.
- De Bonis M, Cavaliere F, Alessandrini F, Lapenna E, Santarelli F, Moscato U, Schiavello R, Possati GF. Topical use of tranexamic acid in coronary artery bypass operations: a double-blind, prospective, randomized, placebo-controlled study. J Thorac Cardiovasc Surg. 2000;119:575–580.
- Vessman J, Stromberg S. Determination of tranexamic acid in biological materials by electron capture gas chromatography after direct derivatization in an aqueous medium. Anal Chem. 1977;49:369–373.
- Lee JH, Park JG, Lim SH, Kim JY, Ahn KY, Kim MY, Park YM. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: A preliminary clinical trial. Dermatol Surg. 2006;32:626.
- Manosroi A, Podjanasoonthon K, Manosroi J. Stability and release of topical tranexamic acid liposome formulations. J Cosmet Sci. 2002;53:375–386.
- Manosroi A, Podjanasoonthona K, Manosroi J. Development of novel topical tranexamic acid liposome formulations. Int J Pharm. 2002;235:61–70.
- Fitzpatrick TB, Arndt KA, el Mofty AM, Pathak MA. Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligo. Arch Dermatol. 1966;93:589–600.
- Sanchez IL, Vazquez M. A hydroquinone solution in the treatment of melasma. Int J Dermatol. 1982;21:55–58.
- Angchaisuksiri P, Aryuchai K, Thanasarnaksorn W, Tantibhaedhyangkul V, Phimolsarnti P, Charuwichitratana S, Tanratanakorn S, Atichartakarn V. Fibrinolytic activity, thrombin generation and safety during long-term treatment with tranexamic acid in Thai patients with melasma. Blood. 2001;98(Part 2):3977.